Prospective randimized double blind study on the effect of post-caesarean section rectal misoprostol on intestinal motility

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201201000343619

Enrollment

218

Registered

2012-01-14

Start date

2010-08-02

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Surgery Return of intestinal motility post-caesarean section

Interventions

Rectal Misoprostol Group

Oxytocin infusion group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women who were scheduled to undergo caesarean section for various indications with risk factors for primary postpartum haemorrhage

Exclusion criteria

Exclusion criteria: 1. patients with serum electrolyte derrangements 2.Gross peritonitis and inevitable sepsis. 3.Patients with previous history of bowel surgery 4.Women who have thyroid diseases, inflammatory bowel disease or complaints of chronic constipation (defined as two or less bowel movements per week).

Design outcomes

Primary

Measure	Time frame
Post-operative flatus pass time	—

Secondary

Measure	Time frame
commencement of regular diet;Gastrointestinal side effects;Need for additional analgesic	—

Countries

Nigeria

Contacts

Public ContactOlusola Fasubaa

Head of Department O&G

ofasubaa@yahoo.com02347039707775

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026